Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

Finasteride for hair loss in young men increases the risk of sexual dysfunction.

Young men taking finasteride for hair loss have a higher risk of sexual dysfunction.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Blocking the androgen receptor in skin cells reduces their growth response to male hormones, suggesting a possible treatment for skin conditions linked to androgens.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

Allopregnanolone is needed for certain brain processing issues caused by D1 dopamine receptor activation.

Finasteride for hair loss increases risk of sexual dysfunction in young men.

The study found that polymorphous light eruption varies among patients and can be distinguished from benign summer light eruption by the time it takes for symptoms to appear after sun exposure.

A new gene, JMJD1C, may affect testosterone levels in men.

Hormonal changes after childbirth and menopause can lead to women's hair loss and facial hair growth, with a need for better treatments.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

Being overweight or obese before pregnancy increases the risk of having a C-section and a larger-than-normal baby in Chile's public health system.

Dental erosion is common in adolescents and is linked to diet and higher socioeconomic status.

Finasteride reduces prostate size and PSA levels in young patients.

The document suggests treating individuals with nonclassic congenital adrenal hyperplasia who show symptoms, especially those related to excess male hormones.

The N363S gene variant does not cause higher adrenal androgen levels in women with polycystic ovary syndrome.

Isoallopregnanolone may be a safe and effective treatment for reducing tics in a mouse model of Tourette syndrome.

Mutations in the CYP21A2 gene are not a major factor in causing PCOS.

Hair care practices and concerns about maintaining hairstyles can reduce how often African American women exercise.

Combining genetic and physical trait analysis improves diagnosis accuracy for monogenic diabetes.

Certain gene variations might increase the risk of a hair loss condition in Koreans.

Despite progress, better treatments and understanding are needed for the high rates of long-term issues and deaths linked to eating disorders.

Thyrotropin-Releasing Hormone helps heal wounds in frog and human skin.

Some women with PCOS have CYP21 mutations and IRS1 variants, but these genetic factors are not major contributors to PCOS.

Spironolactone may help reduce hair loss in androgenic alopecia.

Some synthetic carbohydrate receptors, especially compounds 3 and 15, show strong potential for treating Zika virus.

The document concludes that various findings in rheumatology offer insights into disease severity, treatment responses, and potential risks in medication, with some limitations due to unspecified participant numbers.

Spironolactone may help reduce hair loss in androgenic alopecia.

Surgery to fix a broken upper arm bone can sometimes lead to nerve damage.